A bivalent respiratory syncytial virus (RSV) prefusion F protein-based (RSVpreF) vaccine given during pregnancy elicits neutralizing antibody responses, according to a study published in the April 28 issue of the New England ...
Apr 28, 2022
0
2
Antibodies induced by the RTS,S malaria vaccine can bind strongly to other P. falciparum antigens not contained in the vaccine, and this is associated with greater vaccine protection, according to a new study published in ...
Apr 27, 2022
0
16
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal, (23-26 April), has shown that a longer interval between primary COVID-19 vaccine doses ...
Apr 22, 2022
0
45
Do you blow your nose and rub your itchy eyes more than usual in the spring? Chances are you have hay fever, also called allergic rhinitis, an allergic response that has absolutely nothing to do with hay and everything to ...
Apr 12, 2022
0
27
Although SARS-CoV-2 has taken the world by storm, it's not the only coronavirus that can infect humans. But unlike SARS-CoV-2, common human coronaviruses (HCoVs) generally cause only mild disease. Now, researchers reporting ...
Mar 30, 2022
0
110
The COVID-related death rate among Americans who received Johnson & Johnson's COVID-19 vaccine was more than double that of people who received other vaccines, new data from the Omicron surge show.
Mar 26, 2022
1
322
Infants and toddlers who experienced community infection with SARS-CoV-2, the coronavirus that causes COVID-19, had significantly higher levels of antibodies against the virus compared to adults, according to a study led ...
Mar 22, 2022
0
16
A delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals, according to new research. The findings were published this week in mBio, an open-access journal ...
Mar 17, 2022
0
41
Using mRNA technology like that in the COVID-19 vaccines, researchers have demonstrated a successful way to deliver a potential HIV vaccine, researchers at Duke Human Vaccine Institute report.
Mar 16, 2022
0
173
Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...
Mar 10, 2022
0
33
